PortViewPortView
Quanterix logo

Quanterix (QTRX) Stock Analysis

NASDAQHealthcareMedical - Devices

$2.53+0.60%
1-year price historyRange $2.42 – $8.06
52-week range$2.53
$2.15$8.77

What Quanterix does

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.

Key metrics

Market cap
$118.94M
P/E (TTM)
-0.99
EPS (TTM)
$-2.54
Beta
1.07
Dividend yield
0.00%
Revenue / share
$3.26
50-day avg
$3.51
200-day avg
$4.67
52-week high
$8.77
52-week low
$2.15
CEO
Everett V. Cunningham

ETFs linked to QTRX

Broad-market and Healthcare sector ETFs an investor holding Quanterix is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how QTRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze QTRX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Quanterix?
Quanterix trades under the ticker QTRX on NASDAQ.
Which exchange is QTRX listed on?
QTRX is listed on NASDAQ.
What sector does Quanterix operate in?
Quanterix is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze QTRX in a portfolio?
PortView shows QTRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.